Zobrazeno 1 - 10
of 53
pro vyhledávání: '"S. R. Feldman"'
Publikováno v:
Revista de Biología Tropical, Vol 49, Iss 1, Pp 313-316 (2001)
Monk's tonsure-like gaps develop inside gramineans and other plants. The tonsures of Spartina argentinensis originate as a result of tussock development and disturbance. As the tonsure develops the ring of tillers around it breakes down and new tusso
Externí odkaz:
https://doaj.org/article/58e506cb400c45f28b08fc6289f111da
Publikováno v:
Dermatology online journal. 26(1)
Pyoderma gangrenosum is a rare autoinflammatory skin disease. Treatment is multifactorial, addressing inflammation, pain, underlying disease, if present, and the wound. Gentian violet has been used for hundreds of years in a variety of dermatologic c
Autor:
null T. A. Arcury, null S. R. Feldman, null M. R. Schulz, null Q. Vallejos, null A. Verma, null A. B. Fleischer, null Jr., null S. R. Rapp, null S. F. Davis, null J. S. Preisser, null S. A. Quandt
Publikováno v:
Journal of Agricultural Safety and Health. 13:407-418
Skin diseases are common among farmworkers, yet little research documents their prevalence and risk factors. This analysis documents the prevalence of skin diseases among farmworkers in North Carolina, examines variation in the prevalence across the
Publikováno v:
Skin therapy letter. 20(3)
Prescribing medications off-label is commonplace in dermatology. Recent policy changes on the regulatory abilities of the US FDA and legal precedents regarding this topic have led to intense debate on free speech about off-label drug use by physician
Publikováno v:
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 147(3)
Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit with a multifactorial pathogenesis. Topical and oral antibiotics are a mainstay treatment for inflammatory acne lesions and are widely utilized for all levels of disease severi
Autor:
S R, Feldman
Publikováno v:
The British journal of dermatology. 165(2)
Autor:
L K, Dunn, S R, Feldman
Publikováno v:
Skin therapy letter. 15(4)
Biologic agents were introduced during the past decade as a new class of treatments for chronic psoriasis. These agents provide therapeutic alternatives to traditional topical and systemic therapies. Alefacept, the first such biologic agent, was appr
Autor:
M A, Kinney, S R, Feldman
Publikováno v:
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 144(2)
Psoriasis treatment is evolving through better understanding of patients with psoriasis and the pathogenesis of the disease itself. Current treatment plans for psoriasis consist of topical medications for mild-moderate or localized psoriasis and more
Publikováno v:
The British journal of dermatology. 158(2)
Dermatomyositis is an autoimmune inflammatory muscle disease with characteristic cutaneous findings of heliotrope eruption, Gottron's papules and a photodistributed eruption with poikiloderma.To develop and validate a tool to assist with objective as
Autor:
K M, Cordoro, S R, Feldman
Publikováno v:
Skin therapy letter. 12(7)
To date, the US FDA has approved three tumor necrosis factor (TNF)-a inhibitors for use in dermatology. Etanercept (Enbrel, Amgen-Wyeth), a fully human fusion protein of TNF receptor II bound to the Fc component of human IgG1, is approved for use in